Echo45 Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Echo45 Advisors's LLY Position: Q2 2026 in Review
Echo45 Advisors reduced its Eli Lilly (LLY) stake by 9.5% in Q2 2026, selling an estimated $43.9K and leaving 409 shares worth $491K. The position accounts for 0.25% of the portfolio, ranked #45.
Echo45 Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $521K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Echo45 Advisors held 409 shares of Eli Lilly worth $491K as of Q2 2026.
- Echo45 Advisors sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
- Eli Lilly made up 0.25% of Echo45 Advisors's portfolio in Q2 2026, its #45 holding.
- Echo45 Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Echo45 Advisors's Eli Lilly position peaked at $521K in Q4 2025.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Echo45 Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.